Inhibiting growth and spread of malignancy and retarding DNA breaks
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 28, 1998
Issued Date -
N/A
app pub date -
Sep 16, 1996
filing date -
Feb 14, 1994
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Growth of an adenocarcinoma in the liver, lung, lymph node or mammary tissue in a mammal can be inhibited by orally administering a therapeutically effective dosage of pyruvate in the form of sodium pyruvate, calcium pyruvate or organic esters of pyruvate. The pyruvate treatment also retards the development of breaks in the DNA strands associated with the malignancy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully